IQV
IQVIA Holdings Inc. · Healthcare · Medical - Diagnostics & Research
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 393.01K | $104.01M | n/a | n/a |
| Q2 2026 | 166 | +9 | 123.07M | $23.74B | +12 | −2 |
| Q1 2026 | 159 | -11 | 122.65M | $21.04B | +3 | −15 |
| Q4 2025 | 169 | +1 | 132.77M | $29.93B | +3 | −1 |
| Q3 2025 | 26 | -1 | 77.42M | $14.69B | +1 | −3 |
| Q2 2025 | 25 | +2 | 68.72M | $10.83B | +2 | n/a |
| Q1 2025 | 20 | -1 | 30.89M | $5.44B | n/a | −1 |
| Q4 2024 | 21 | +1 | 31.11M | $6.11B | +1 | n/a |
| Q3 2024 | 19 | -1 | 19.49M | $4.61B | +1 | −2 |
| Q2 2024 | 20 | n/a | 21.58M | $4.56B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 326.42K | -52.1% | $87.76M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 58.67K | +39.6% | $14.19M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 7.92K | -41.9% | $2.07M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,061 holders, 150.48M shares, $24.99B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.67K sh · $697,228
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology